CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Daewoong Pharmaceutical Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Daewoong Pharmaceutical Co., Ltd.
35-14, Jeyakgongdan 4-gil, Hyangnam-eup
Phone: +82 25508800p:+82 25508800 HWASEONG, 18623  South Korea Ticker: 069620069620

Business Summary
DAEWOONG PHARMACEUTICAL CO.,LTD. is a Korea-based company principally engaged in the manufacture and distribution of pharmaceuticals. The Company’s products mainly include antihypertensive drugs, antianemic agents, antidiabetic agents, antiemetic agents, antihistamine agents, antimicrobials, antineoplastics, antiobesity agents, antipyretic agents, analgesic agents, anti-inflammatory agents, biosimilars, remedies for bone and joint diseases, cardiovascular treatments, central nervous system treatments, digestive agents, dermatologic agents, gastrointestinal agents, health supplements, respiratory remedies and others. The Company distributes its products within domestic markets and to overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201912/31/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Yeong HwanYoon 79
President, Co-Chief Executive Officer, Director Jong WukLee 64 1/1/2009 5/26/2006
Vice Chairman of the Board, Co-Chief Executive Officer Jae HunYoon 51 5/29/2009 5/29/2009
9 additional Officers and Directors records available in full report.

Business Names
Business Name
069620
Daewoong Pharmaceutical Co., Ltd.

General Information
Number of Employees: 1,256 (As of 12/31/2010)
Outstanding Shares: 10,320,870 (As of 9/30/2019)
Shareholders: 12,739
Stock Exchange: SEO
Fax Number: +82 220591690


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 10, 2019